Tarsons Products Ltd

Tarsons Products Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Tarsons Products Ltd

₹ 319 -0.96%
05 Sep - close price
tarsons.com BSE: 543399 NSE: TARSONS
About

Tarsons Products Ltd. (TPL) is an Indian labware company engaged in the designing, development, manufacturing, and marketing of 'consumables', 'reusables' and 'others' including benchtop equipment, used in various laboratories across research organizations, academia institutes, pharmaceutical companies, Contract Research Organizations, Diagnostic companies, and hospitals[1]

Key Points

India’s Leading Labware Company[1]
One of the leading Indian labware company engaged in designing, development, manufacturing and marketing of consumables, reusables and others (including benchtop
equipment & instruments)

Website BSE NSE
  • Market Cap ₹ 1,699 Cr.
  • Current Price ₹ 319
  • High / Low ₹ 492 / 280
  • Stock P/E 61.7
  • Book Value ₹ 118
  • Dividend Yield 0.63 %
  • ROCE 6.93 %
  • ROE 4.75 %
  • Face Value ₹ 2.00
Edit ratios

Pros

Cons

  • Stock is trading at 2.70 times its book value
  • Company might be capitalizing the interest cost
  • Working capital days have increased from 77.8 days to 156 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Equipment & Supplies Medical Equipment & Supplies

Part of BSE Healthcare BSE SmallCap BSE Allcap

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
60.23 67.56 69.15 76.05 70.66 84.94 61.79 105.72 84.80 99.25 95.68 112.69 91.36
29.56 32.71 32.39 37.58 37.52 40.61 38.91 75.48 66.04 73.94 66.04 75.67 66.66
Operating Profit 30.67 34.85 36.76 38.47 33.14 44.33 22.88 30.24 18.76 25.31 29.64 37.02 24.70
OPM % 50.92% 51.58% 53.16% 50.59% 46.90% 52.19% 37.03% 28.60% 22.12% 25.50% 30.98% 32.85% 27.04%
1.81 0.66 1.98 1.45 2.46 2.58 3.24 3.38 2.91 8.43 0.85 3.78 3.34
Interest 0.75 0.58 0.83 1.56 1.37 0.45 2.51 4.25 4.32 4.84 5.03 5.20 5.07
Depreciation 3.46 3.37 4.57 4.81 5.35 7.24 10.06 12.33 11.03 14.03 17.41 20.03 19.94
Profit before tax 28.27 31.56 33.34 33.55 28.88 39.22 13.55 17.04 6.32 14.87 8.05 15.57 3.03
Tax % 25.54% 25.35% 25.52% 25.78% 25.66% 24.89% 26.72% 39.50% 36.39% 30.80% 34.66% 34.49% 41.25%
21.05 23.56 24.84 24.90 21.47 29.46 9.93 10.32 4.02 10.29 5.26 10.20 1.78
EPS in Rs 1,095.21 1,225.81 4.88 4.89 4.04 5.54 1.87 1.94 0.76 1.93 0.99 1.92 0.33
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2024 Mar 2025 TTM
229 301 296 392 399
125 148 196 282 282
Operating Profit 103 153 100 111 117
OPM % 45% 51% 34% 28% 29%
5 8 11 16 16
Interest 3 4 10 20 20
Depreciation 14 22 40 62 71
Profit before tax 92 135 61 45 42
Tax % 25% 25% 30% 34%
69 101 43 30 28
EPS in Rs 3,583.25 18.92 8.01 5.60 5.17
Dividend Payout % 0% 0% 25% 0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 9%
TTM: 32%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: -34%
TTM: -31%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: -28%
1 Year: -31%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: 5%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2024 Mar 2025
Equity Capital 0.19 11 11 11
Reserves 244 479 602 620
34 22 269 339
18 33 90 111
Total Liabilities 296 544 972 1,080
120 189 336 536
CWIP 22 32 267 233
Investments 0 0 0 0
153 323 369 311
Total Assets 296 544 972 1,080

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2024 Mar 2025
68 83 103 114
-64 -138 -285 -145
-27 130 136 39
Net Cash Flow -23 75 -47 8

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2024 Mar 2025
Debtor Days 75 79 96 74
Inventory Days 277 478 572 355
Days Payable 35 75 65 44
Cash Conversion Cycle 317 482 602 385
Working Capital Days 108 150 -1 156
ROCE % 35% 7%

Shareholding Pattern

Numbers in percentages

4 Recently
Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025
47.31% 47.31% 47.31% 47.31% 47.31% 47.31% 47.31% 47.31% 47.31% 47.31% 47.31% 47.31%
9.90% 9.60% 9.16% 8.64% 7.85% 6.83% 8.16% 7.95% 8.04% 7.51% 9.53% 9.14%
8.13% 8.52% 8.45% 7.38% 3.15% 2.60% 0.17% 0.11% 0.21% 0.51% 0.30% 0.04%
34.67% 34.59% 35.09% 36.67% 41.68% 43.27% 44.36% 44.63% 44.45% 44.69% 42.89% 43.50%
No. of Shareholders 1,07,0111,07,9451,05,3041,07,4401,08,2361,07,5641,02,8661,05,33099,58696,92793,41790,891

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls